Media

Please see below for Adaptive’s news releases and press on the Company.

Press on Company

Adaptive TCR Seeks to Dominate New Industry in Profiling The Immune System

Fred Hutchinson Cancer Research Center: When it comes to the immune system, we’re all more alike than previously thought, study finds

Medline Plus: Immune System Research Sees Many Similarities Among People

CNN: Differences found in individuals’ immune systems

Bloomberg Businessweek: Immune System Research Sees Many Similarities Among People

Adaptive TCR, a Fred Hutch Spinoff, nabs $4.5M to uncover Immune System Secrets.

Press Releases

Adaptive TCR changes name to Adaptive Biotechnologies

Study in the Journal of Immunological Methods confirms accuracy, sensitivity of Adaptive TCR’s immune profiling technology.

Adaptive TCR Adds Industry Heavyweights to Board of Directors and Advisory Boards

Seminal Cancer Study Uses ImmunoSEQ to Validate Results.

Adaptive TCR raises $5.8 million in Series B funding to expand immunoSEQ platform.

Adaptive TCR names Julie Rubinstein Vice President of Business Development, Oncology.

Adaptive TCR Corporation Announces QTDP Grant Awards of Over $1.0 million

Craig Weissman, Salesforce.com Chief Technology Officer, joins Adaptive TCR Board of Directors

Newly published report highlights the power of immunoSEQ

Adaptive Announces Tiered Pricing

MORE PRESS RELEASES